Henry Schein (HSIC) News & Sentiment

HSIC is showing positive price movement, strong momentum, good volume, and relative strength, which makes it a promising investment with a 2.6 reward-to-risk ratio. The stock is on the rise, trading above its 30-week EMA, and has positive momentum in both the short and long term, as shown by the PPO. Additionally, institutional buying is boosting volume trends, and HSIC has been doing better than the S&P 500 since December 2024.

Henry Schein is the biggest supplier of healthcare products and services for dental and medical offices, and it has been steadily growing through acquisitions. Although shares fell by 3%, the company's management expects growth to continue into 2025, which supports a positive outlook on the stock. In the fourth quarter of 2024, the company saw a 5.8% rise in revenue, thanks to both organic growth and acquisitions, along with notable gains in net income and operating cash flow.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the leading provider of healthcare solutions for dental and medical offices, announced that it will speak at the Leerink Global Healthcare Conference on Tuesday, March 11th, 2025, at 1:40 p.m. Eastern time, held at the W South Beach hotel in Miami. You can listen to Henry Schein's presentations through a live webcast at www.henryschein.com/IRwebcasts. Recordings will also be accessible on the Henry Schein website.

Henry Schein, Inc. (NASDAQ:HSIC) will hold its Q4 2024 Earnings Conference Call on February 25, 2025, at 8:00 AM ET. The call will feature company representatives, including Graham Stanley, Stanley Bergman, and Ronald South, along with various conference call participants from different financial institutions. The operator welcomes everyone and notes that all participants are currently in listen-only mode.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the biggest supplier of health care solutions for dental and medical offices, has announced its financial results for the fourth quarter and the entire year ending December 28, 2024. The results and forecasts shared today align with the initial financial information given on January 29th. "Our financial results for the fourth quarter show a stable performance in both dental and medical sectors."

Henry Schein's results for the fourth quarter show that the dental and medical markets are stable.

In addition to Wall Street's predictions for Henry Schein's (HSIC) earnings, take a look at forecasts for some important metrics to better understand how the company performed in the quarter that ended in December 2024.

Henry Schein is anticipated to show strong sales in both of its sectors during the fourth quarter of 2024, as well as a good recovery from the cyber incident.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced that Stanley M. Bergman, the Chairman and CEO, has been honored with the NAW Dirk Van Dongen Lifetime Achievement Award. This award recognizes individuals who have shown consistent leadership, service, and involvement with NAW and the distribution sector over the years. Mr. Bergman received this accolade during the 2025 NAW Executive Summit.